BALA CYNWYD, Pa., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Capital Bancorp, Inc. (Nasdaq – CBNK)
Under the terms of the Merger Agreement, Capital will be acquired by Peoples Bancorp Inc. (“Peoples”) (Nasdaq - PEBO) whereby shareholders of Capital will receive 1.11 shares of Peoples common stock for each share of Capital common stock. Based on Peoples' 20-day volume-weighted average closing price of $39.41 per share as of September 29, 2026, the aggregate transaction value is approximately $728.1 million, or $43.75 per share. The investigation concerns whether the Capital Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/capital-bancorp-inc-nasdaq-cbnk/.
Lifecore Biomedical, Inc. (Nasdaq – LFCR)
Under the terms of the Merger Agreement, Lifecore Biomedical will be acquired by Webster Equity Partners for $6.28 per share in cash at closing plus one non-tradable contingent value right (CVR) per share. The investigation concerns whether the Lifecore Biomedical Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/lifecore-biomedical-inc-nasdaq-lfcr/.
MISTRAS Group, Inc. (NYSE – MG)
Under the terms of the Merger Agreement, MISTRAS Group will be acquired by affiliates of H.I.G. Capital for $20.35 per share in an all-cash transaction, representing an enterprise value of approximately $866 million, including outstanding debt. The investigation concerns whether the MISTRAS Group Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/mistras-group-inc-nyse-mg/.
Utz Brands, Inc. (NYSE – UTZ)
Under the terms of the Merger Agreement, Utz will be acquired by Intersnack Group GmbH & Co. KG (“Intersnack”) for $14.25 per share in cash representing an enterprise value of approximately $2.9 billion. The investigation concerns whether the Utz Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/utz-brands-inc-nyse-utz/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
